Cargando…

Health-related quality of life in high-grade glioma patients

Gliomas are malignant primary brain tumors and yet incurable. Palliation and the maintenance or improvement of the patient's quality of life is therefore of main importance. For that reason, health-related quality of life (HRQoL) has become an important outcome measure in clinical trials, next...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dirven, Linda, Aaronson, Neil K., Heimans, Jan J., Taphoorn, Martin J.B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sun Yat-sen University Cancer Center 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905089/ https://www.ncbi.nlm.nih.gov/pubmed/24384239 http://dx.doi.org/10.5732/cjc.013.10214

Ejemplares similares

Impact of neurocognitive deficits on patient–proxy agreement regarding health-related quality of life in low-grade glioma patients
por: Ediebah, Divine E., et al.
Publicado: (2016)

Neurocognitive impairment and patient–proxy agreement on health-related quality of life evaluations in recurrent high-grade glioma patients
por: Caramanna, Ivan, et al.
Publicado: (2022)

Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide
por: Koekkoek, Johan A. F., et al.
Publicado: (2015)

The Impact of the Timing of Health-Related Quality of Life Assessments on the Actual Results in Glioma Patients: A Randomized Prospective Study
por: Peeters, Marthe C.M., et al.
Publicado: (2020)

Research Objectives, Statistical Analyses and Interpretation of Health-Related Quality of Life Data in Glioma Research: A Systematic Review
por: Coomans, Marijke B., et al.
Publicado: (2020)

Importance of evaluating health-related quality of life issues in survivors of WHO grade II or III gliomas
por: Dirven, Linda
Publicado: (2022)

Evaluating the lack of impact of the e-health application Oncokompas on outcomes in incurably ill cancer patients
por: Dirven, Linda, et al.
Publicado: (2022)

Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patients
por: Coomans, Marijke B, et al.
Publicado: (2020)

Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period
por: Coomans, Marijke B, et al.
Publicado: (2022)

Prediagnostic presentations of glioma in primary care: a case–control study
por: Peeters, Marthe CM, et al.
Publicado: (2019)

Antiepileptic drug treatment in the end-of-life phase of glioma patients: a feasibility study
por: Koekkoek, Johan A. F., et al.
Publicado: (2015)

Retention rates of antiepileptic drugs in glioma patients: the most appropriate outcome
por: van der Meer, Pim B, et al.
Publicado: (2020)

Health-related quality of life of cranial WHO grade I meningioma patients: are current questionnaires relevant?
por: Zamanipoor Najafabadi, Amir H., et al.
Publicado: (2017)

Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study
por: Koekkoek, Johan A F, et al.
Publicado: (2014)

MEG Network Differences between Low- and High-Grade Glioma Related to Epilepsy and Cognition
por: van Dellen, Edwin, et al.
Publicado: (2012)

Health-related quality of life in meningioma
por: Haider, Sameah, et al.
Publicado: (2021)

Health-related quality of life in adults with low-grade gliomas: a systematic review
por: Rimmer, Ben, et al.
Publicado: (2022)

Individual changes in neurocognitive functioning and health-related quality of life in patients with brain oligometastases treated with stereotactic radiotherapy
por: van der Meer, Pim B., et al.
Publicado: (2018)

The association between preoperative edema and postoperative cognitive functioning and health-related quality of life in WHO grade I meningioma patients
por: van Nieuwenhuizen, David, et al.
Publicado: (2019)

Effectiveness of Antiseizure Medication Duotherapies in Patients With Glioma: A Multicenter Observational Cohort Study
por: van der Meer, Pim B., et al.
Publicado: (2022)

Effectiveness of Antiseizure Medication Triple Therapy in Patients With Glioma With Refractory Epilepsy: An Observational Cohort Study
por: van der Meer, Pim B., et al.
Publicado: (2023)

First‐line levetiracetam versus enzyme‐inducing antiseizure medication in glioma patients with epilepsy
por: van der Meer, Pim B., et al.
Publicado: (2022)

Does early resection of presumed low-grade glioma improve survival? A clinical perspective
por: Wijnenga, Maarten M. J., et al.
Publicado: (2017)

Efficacy of antiepileptic drugs in glioma patients with epilepsy: a systematic review
por: de Bruin, Marjolein E, et al.
Publicado: (2021)

Effect of antiepileptic drugs in glioma patients on self-reported depression, anxiety, and cognitive complaints
por: van der Meer, Pim B., et al.
Publicado: (2021)

Impact of timing of antiseizure medication withdrawal on seizure recurrence in glioma patients: a retrospective observational study
por: van der Meer, Pim B., et al.
Publicado: (2023)

Disturbed functional brain networks and neurocognitive function in low-grade glioma patients: a graph theoretical analysis of resting-state MEG
por: Bosma, Ingeborg, et al.
Publicado: (2009)

Health-related quality of life and distress in elderly vs. younger patients with high-grade glioma—results of a multicenter study
por: Renovanz, Mirjam, et al.
Publicado: (2020)

The long-term caregiver burden in World Health Organization grade I and II meningioma: It is not just the patient
por: Zamanipoor Najafabadi, Amir H, et al.
Publicado: (2020)

Dynamics in cognition and health-related quality of life in grade 2 and 3 gliomas after surgery
por: Svedung Wettervik, Teodor, et al.
Publicado: (2022)

Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status?
por: Coomans, Marijke B, et al.
Publicado: (2019)

The impact of current treatment modalities on the outcomes of patients with melanoma brain metastases: A systematic review
por: van Opijnen, Mark P., et al.
Publicado: (2019)

The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamide
por: van Opijnen, Mark P., et al.
Publicado: (2021)

Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study
por: Kerkhof, M., et al.
Publicado: (2019)

First‐line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid
por: van der Meer, Pim B., et al.
Publicado: (2021)

Long-term impact of adult WHO grade II or III gliomas on health-related quality of life: A systematic review
por: Frances, Sé Maria, et al.
Publicado: (2021)

Using machine learning to predict health-related quality of life outcomes in patients with low grade glioma, meningioma, and acoustic neuroma
por: Karri, Roshan, et al.
Publicado: (2022)

Aggressiveness of care at end of life in patients with high‐grade glioma
por: Harrison, Rebecca A., et al.
Publicado: (2021)

The influence of low-grade glioma on resting state oscillatory brain activity: a magnetoencephalography study
por: Bosma, I., et al.
Publicado: (2008)

Health-related quality of life in glioma patients in China
por: Cheng, Jin-xiang, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_67nospd03fhavms1or1biav66s